Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
SeqCure Immunology AB
AB
Active
Org 5590947031
Nanna Svartz Väg 2, 171 65
Solna
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2016 · 9 years old
1 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
SeqCure Immunology AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
HV
Hans Vidar Wendel-Hansen
Chief Executive Officer
Chief Executive Officer
2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
EK
Emma Kristina Lindh
Deputy Board Member
Deputy Board Member
2022
RP
Robert Per-Anders Wallin
Chairman
Chairman
2022
BL
Bernt Ludvig Linton
Board of Directors
Board of Directors
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on SeqCure Immunology AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
